Jun Cai Bai
Chief Executive Officer chez Ambio Holdings, Inc.
Profil
Jun Cai Bai is the founder of Ambio Holdings, Inc. (founded in 2014) and Ambio Pharmaceuticals (founded in 2020), where he holds the titles of Executive Chairman & Chief Executive Officer and Chairman & Chief Executive Officer, respectively.
He currently holds multiple positions, including Chairman at AmbioPharm, Inc. (South Carolina) since 2007, Chairman at Shanghai Chemspec Ambio Co. Ltd.
since 2018, Director at Ambio, Inc. since 2011, Director at Ambio Product Management, Inc. since 2016, Director at Ambio Pharma Europe Ltd.
since 2018, and Director at AmbioPharm (Switzerland) AG since 2020.
Dr. Bai's former position was President & Chief Executive Officer at American Peptide Co., Inc. Dr. Bai obtained a doctorate degree from Shanghai Institute of Organic Chemistry in 1988 and an undergraduate degree from Inner Mongolia University in 1983.
Postes actifs de Jun Cai Bai
| Sociétés | Poste | Début |
|---|---|---|
Ambio Holdings, Inc.
 Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC. | Chief Executive Officer | 05/11/2014 |
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Chief Executive Officer | 08/10/2020 |
AmbioPharm, Inc. (South Carolina)
 AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | Chairman | - |
Ambio, Inc.
 Ambio, Inc. Miscellaneous Commercial ServicesCommercial Services Ambio, Inc. is an American company that provides a platform for searching, comparing, requesting, and purchasing sustainable plastics from top material distributors and manufacturers. The private company is based in SC. The company's platform allows customers to quickly and easily find recycled and bio-based plastic materials at competitive prices, while also saving time by handling the search and logistics from start to finish. | Director/Board Member | 07/11/2011 |
| Ambio Product Management, Inc. | Director/Board Member | 16/11/2016 |
| Shanghai Chemspec Ambio Co. Ltd. | Chairman | 26/04/2018 |
Ambio Pharma Europe Ltd.
 Ambio Pharma Europe Ltd. MiscellaneousMiscellaneous Ambio Pharma Europe Ltd. is an Irish private company that functions as an investment holding company. | Director/Board Member | 15/05/2018 |
| AmbioPharm (Switzerland) AG | Director/Board Member | 27/10/2020 |
Anciens postes connus de Jun Cai Bai
| Sociétés | Poste | Fin |
|---|---|---|
American Peptide Co., Inc.
 American Peptide Co., Inc. Pharmaceuticals: MajorHealth Technology American Peptide Co., Inc. is a pharmaceutical company that specializes in manufacturing and distributing pharmaceutical products. The company is based in Sunnyvale, CA. American Peptide Co. was acquired by Bachem Americas, Inc. from Otsuka Holdings Co., Ltd. on March 27, 2015. | Chief Executive Officer | - |
Formation de Jun Cai Bai
| Shanghai Institute of Organic Chemistry | Doctorate Degree |
| Inner Mongolia University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
American Peptide Co., Inc.
American Peptide Co., Inc. Pharmaceuticals: MajorHealth Technology American Peptide Co., Inc. is a pharmaceutical company that specializes in manufacturing and distributing pharmaceutical products. The company is based in Sunnyvale, CA. American Peptide Co. was acquired by Bachem Americas, Inc. from Otsuka Holdings Co., Ltd. on March 27, 2015. | Health Technology |
Ambio Holdings, Inc.
Ambio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC. | Health Technology |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Commercial Services |
AmbioPharm, Inc. (South Carolina)
AmbioPharm, Inc. (South Carolina) Pharmaceuticals: MajorHealth Technology AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023. | Health Technology |
Ambio, Inc.
Ambio, Inc. Miscellaneous Commercial ServicesCommercial Services Ambio, Inc. is an American company that provides a platform for searching, comparing, requesting, and purchasing sustainable plastics from top material distributors and manufacturers. The private company is based in SC. The company's platform allows customers to quickly and easily find recycled and bio-based plastic materials at competitive prices, while also saving time by handling the search and logistics from start to finish. | Commercial Services |
| Ambio Product Management, Inc. | |
| Shanghai Chemspec Ambio Co. Ltd. | |
Ambio Pharma Europe Ltd.
Ambio Pharma Europe Ltd. MiscellaneousMiscellaneous Ambio Pharma Europe Ltd. is an Irish private company that functions as an investment holding company. | Miscellaneous |
| AmbioPharm (Switzerland) AG |
